Showing results (2561-2570 of 3,768) with videos related to

Sort By:
Pageof 377
International Journal of Molecular Sciences|September 14, 2024
Characterization of Stealth Liposome-Based Nanoparticles Encapsulating the ACAT1/SOAT1 Inhibitor F26: Efficacy and Toxicity Studies In Vitro and in Wild-Type MiceJunghoon Lee, Adrianna L De La Torre, Felix L Rawlinson, et al.
JAMA Cardiology|August 14, 2024
Verinurad Plus Allopurinol for Heart Failure With Preserved Ejection Fraction: The AMETHYST Randomized Clinical TrialDalane W Kitzman, Adriaan A Voors, Robert J Mentz, et al.
Journal of Clinical Immunology|May 11, 1991
Monoclonal antibody therapy of human cancer: taking the HER2 protooncogene to the clinicH M Shepard, G D Lewis, J C Sarup, et al.
BMJ Open|April 16, 2013
Prevention and management of chronic disease in Aboriginal and Islander Community Controlled Health Services in Queensland: a quality improvement study assessing change in selected clinical performance indicators over time in a cohort of servicesK S Panaretto, K L Gardner, S Button, et al.
European Heart Journal|December 18, 2012
A diabetes-predictive amino acid score and future cardiovascular diseaseMartin Magnusson, Gregory D Lewis, Ulrika Ericson, et al.
Sports Medicine (Auckland, N.Z.)|June 8, 2013
Role of intensive training in the growth and maturation of artistic gymnastsRobert M Malina, Adam D G Baxter-Jones, Neil Armstrong, et al.
Circulation. Heart Failure|April 11, 2013
Prolonged mean VO2 response time in systolic heart failure: an indicator of impaired right ventricular-pulmonary vascular functionNeal A Chatterjee, Ryan M Murphy, Rajeev Malhotra, et al.
International Journal of Radiation Oncology, Biology, Physics|July 8, 2020
Machine Segmentation of Pelvic Anatomy in MRI-Assisted Radiosurgery (MARS) for Prostate Cancer BrachytherapyJeremiah W Sanders, Gary D Lewis, Howard D Thames, et al.
Science Advances|July 9, 2020
Vaccine-mediated protection against Campylobacter-associated enteric diseaseBenjamin K Quintel, Kamm Prongay, Anne D Lewis, et al.
Journal of Translational Medicine|August 5, 2020
Impact of initial treatment and prognostic factors on postprogression survival in BRAF-mutated metastatic melanoma treated with dacarbazine or vemurafenib ± cobimetinib: a pooled analysis of four clinical trialsPaolo A Ascierto, Antoni Ribas, James Larkin, et al.
Pageof 377